Apexigen, Inc. Depreciation
Apexigen, Inc. reported Depreciation of $17.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-08-10
- Apexigen, Inc. depreciation for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Apexigen, Inc. depreciation for the quarter ending 2023-03-31 was $17.00K, a 39.29% decline year-over-year.
- Apexigen, Inc. depreciation for the quarter ending 2022-12-31 was $26.00K, a 0.00% change year-over-year.
- Apexigen, Inc. depreciation for the quarter ending 2022-09-30 was $29.00K.
- Apexigen, Inc. depreciation for fiscal 2022 was $110.00K, a 4.76% increase from fiscal 2021.
- Apexigen, Inc. depreciation for fiscal 2021 was $105.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $17.00K 10-Q · filed 2023-08-10 | $43.00K derived: sum of 3 quarters · filed 2023-08-10 | $72.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-15 | $43.00K derived: sum of 2 quarters · filed 2023-05-15 | $72.00K derived: sum of 3 quarters · filed 2023-05-15 | $99.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $55.00K derived: sum of 2 quarters · filed 2023-02-22 | $82.00K derived: sum of 3 quarters · filed 2023-08-10 | $110.00K 10-K · filed 2023-02-22 |
| 2022-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $56.00K derived: sum of 2 quarters · filed 2023-08-10 | $84.00K 10-Q · filed 2022-11-14 | $110.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $55.00K 10-Q · filed 2023-08-10 | $81.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $28.00K 10-Q · filed 2023-05-15 | $54.00K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $105.00K 10-K · filed 2023-02-22 | ||
| 2021-09-30 | $79.00K 10-Q · filed 2022-11-14 |